BioSpace

FDA issues warning over Eurofins’ selective recording that 'compromises' data

Inconsistent reporting at a Pennsylvania site affected microbiological analyses of components and drug products that analytical testing service provider Eurofins ran for customers.

By BioSpace

1 min read
FDA issues warning over Eurofins’ selective recording that 'compromises' data
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights